Weekly Analysts’ Ratings Changes for Elanco Animal Health (ELAN)

A number of firms have modified their ratings and price targets on shares of Elanco Animal Health (NASDAQ: ELAN) recently:

  • 6/25/2019 – Elanco Animal Health was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $38.00 price target on the stock. According to Zacks, “Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. “
  • 6/21/2019 – Elanco Animal Health was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. “
  • 6/19/2019 – Elanco Animal Health was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $37.00 price target on the stock. According to Zacks, “Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. “
  • 6/6/2019 – Elanco Animal Health was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. “
  • 6/5/2019 – Elanco Animal Health was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $37.00 price target on the stock. According to Zacks, “Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. “
  • 5/22/2019 – Elanco Animal Health is now covered by analysts at Guggenheim. They set a “neutral” rating on the stock.
  • 5/21/2019 – Elanco Animal Health was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. “
  • 5/17/2019 – Elanco Animal Health was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $37.00 price target on the stock. According to Zacks, “Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. “
  • 5/14/2019 – Elanco Animal Health was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. “
  • 5/10/2019 – Elanco Animal Health had its price target raised by analysts at BMO Capital Markets from $32.00 to $35.00. They now have a “market perform” rating on the stock.

Shares of NASDAQ:ELAN opened at $34.79 on Wednesday. Elanco Animal Health has a 52-week low of $28.00 and a 52-week high of $37.61. The business has a 50-day moving average price of $32.56.

Elanco Animal Health (NASDAQ:ELAN) last announced its quarterly earnings data on Thursday, May 9th. The company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.03. The firm had revenue of $731.10 million during the quarter, compared to analysts’ expectations of $743.40 million. During the same quarter in the previous year, the business earned $0.33 earnings per share. The company’s revenue for the quarter was down .7% compared to the same quarter last year.

In other news, Director John P. Bilbrey acquired 7,750 shares of Elanco Animal Health stock in a transaction dated Monday, May 13th. The stock was purchased at an average cost of $32.39 per share, for a total transaction of $251,022.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Large investors have recently made changes to their positions in the company. Primecap Management Co. CA raised its position in Elanco Animal Health by 516.8% during the first quarter. Primecap Management Co. CA now owns 30,607,906 shares of the company’s stock valued at $981,596,000 after acquiring an additional 25,645,707 shares in the last quarter. BlackRock Inc. raised its position in Elanco Animal Health by 618.1% during the first quarter. BlackRock Inc. now owns 19,559,113 shares of the company’s stock valued at $627,262,000 after acquiring an additional 16,835,410 shares in the last quarter. Lazard Asset Management LLC purchased a new position in Elanco Animal Health during the first quarter valued at approximately $341,261,000. OppenheimerFunds Inc. purchased a new position in Elanco Animal Health during the first quarter valued at approximately $310,058,000. Finally, American Century Companies Inc. raised its position in Elanco Animal Health by 327.2% during the first quarter. American Century Companies Inc. now owns 8,875,571 shares of the company’s stock valued at $284,640,000 after acquiring an additional 6,797,761 shares in the last quarter.

There is no company description available for Elanco Animal Health Inc

Recommended Story: What is dollar cost averaging (DCA)?

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.